James Antal Net Worth

The estimated Net Worth of James Antal is at least $1.67 Milión dollars as of 14 June 2022. Mr. Antal owns over 22,831 units of SIGA Technologies Inc stock worth over $929,032 and over the last 20 years he sold SIGA stock worth over $618,600. In addition, he makes $127,000 as Independent Director at SIGA Technologies Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Antal SIGA stock SEC Form 4 insiders trading

James has made over 21 trades of the SIGA Technologies Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 22,831 units of SIGA stock worth $171,461 on 14 June 2022.

The largest trade he's ever made was exercising 30,333 units of SIGA Technologies Inc stock on 16 November 2016 worth over $1,380,151,500. On average, James trades about 7,465 units every 92 days since 2004. As of 14 June 2022 he still owns at least 123,706 units of SIGA Technologies Inc stock.

You can see the complete history of Mr. Antal stock trades at the bottom of the page.

James Antal biography

James J. Antal CPA serves as Independent Director of the Company. Mr. Antal has served as a director of SIGA since November 2004. Mr. Antal has been an active consultant and founding investor in several Southern California based emerging companies since his retirement from Experian, a $1.6 billion global information services subsidiary of UK-based GUS plc. He has served as Chief Financial Advisor to Black Mountain Gold Coffee Co. (2003 to 2005), and as Chief Financial Officer of Pathway Data, Inc. (2005 to 2009). Mr. Antal joined the board of directors and served as the chairman of the audit committee for Cleveland Bio Labs, Inc. since its initial public offering in July 2006 until 2016. Mr. Antal was the Chief Financial Officer and Chief Investment Officer from 1996 to 2002 for Experian. Prior to the GUS acquisition of Experian (the former TRW Inc. Information Systems and Services businesses), Mr. Antal held various finance positions with TRW from 1978 to 1996, including Senior Vice President of Finance for TRW Information Systems and Services and TRW Inc. and Corporate Director of Financial Reporting and Accounting. He earned his undergraduate degree in accounting from The Ohio State University in 1973, and became a certified public accountant (Ohio) in 1974. He engaged in active practice as a CPA with Ernst & Ernst until 1978. Mr. Antal has served as a director of First American Real Estate Solutions, an Experian joint venture with First American Financial Corp. Mr. Antal has many years of valuable business, leadership and management experience that provides him with insight into many aspects of SIGA’s business, including an understanding of corporate finance, financial statements, accounting matters and capital markets. Mr. Antal also brings financial experience to the Board of Directors through his 32-year career as an entrepreneur, his various financial positions at other public companies and through his prior service as chairman of the audit committee for Cleveland Bio Labs.

What is the salary of James Antal?

As the Independent Director of SIGA Technologies Inc, the total compensation of James Antal at SIGA Technologies Inc is $127,000. There are 12 executives at SIGA Technologies Inc getting paid more, with Daniel Luckshire having the highest compensation of $1,684,000.

How old is James Antal?

James Antal is 69, he's been the Independent Director of SIGA Technologies Inc since 2004. There are 2 older and 9 younger executives at SIGA Technologies Inc. The oldest executive at SIGA Technologies Inc is Thomas Constance, 83, who is the Independent Director.

What's James Antal's mailing address?

James's mailing address filed with the SEC is C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK, NY, 10065.

Insiders trading at SIGA Technologies Inc

Over the last 21 years, insiders at SIGA Technologies Inc have traded over $65,185,125 worth of SIGA Technologies Inc stock and bought 6,065,626 units worth $33,817,674 . The most active insiders traders include Holdings Incperelman Ronald..., Pharma Inc Transtech a Adnan M M Mjalli. On average, SIGA Technologies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $1,122,865. The most recent stock trade was executed by Dennis E Hruby on 1 July 2024, trading 32,258 units of SIGA stock currently worth $242,258.

What does SIGA Technologies Inc do?

at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.

Complete history of Mr. Antal stock trades at Cytocom Inc a SIGA Technologies Inc

SIGA Technologies Inc executives and stock owners

SIGA Technologies Inc executives and other stock owners filed with the SEC include:

• Daniel Luckshire,
  Chief Financial Officer, Executive Vice President, Secretary
• Dr. Phillip Louis Gomez III, M.D., Ph.D.,
  CEO & Director
• Phillip Gomez,
  Chief Executive Officer, Director
• Robin Abrams,
  Chief Administrative Officer, General Counsel
• Dr. Dennis E. Hruby,
  Exec. VP & Chief Scientific Officer
• Dennis Hruby,
  Chief Scientific Officer, Vice President
• Daniel J. Luckshire,
  Exec. VP, CFO & Sec.
• Robin E. Abrams,
  Gen. Counsel & Chief Admin. Officer
• Eric Rose,
  Chairman of the Board
• Julie Kane,
  Independent Director
• Michael Plansky,
  Independent Director
• Joseph Marshall,
  Independent Director
• James Antal,
  Independent Director
• Thomas Constance,
  Independent Director
• Herb Vloedman,
  Chief Information Officer
• Tove C. Bolken,
  Sr. VP of Operations & Chief Supply Chain Officer
• Diem Nguyen,
  Chief Executive Officer
• Larry R. Miller,
  General Counsel
• Holdings Incperelman Ronald...,
  
• Bruce Slovin,
  Director
• Paul G Savas,
  
• Jeffrey B Kindler,
  
• Scott M Hammer,
  Director
• Donald G Drapkin,
  Director
• Bernard L Kasten,
  Chief Executive Officer
• Ayelet Dugary,
  Acting Chief Financial Officer
• Judy S Slotkin,
  Director
• Michael Md Weiner,
  Director
• Thomas N Konatich,
  CFO, Secretary and Treasurer
• Adnan M M Mjalli,
  Director
• John Odden,
  VP - Business Development
• Ronald O Mac Andrews & Forb...,
  
• William C Bevins,
  Director
• Susan K Burgess,
  President
• Michael J Bayer,
  Director
• Frances F Townsend,
  Director
• William J Ii Haynes,
  Executive VP & General Counsel
• Steven L Fasman,
  Director
• Pharma Inc Transtech,
  10% owner
• & Forbes Holdings Inc.Perel...,
  
• Mehmet C Md Oz,
  Director
• Donald G Drapkin,
  Director
• Evan A. Knisely,
  
• Edward P. Taibi,
  
• Holly L. Phillips,
  
• Jaymie A Durnan,
  
• Gary J. Nabel,
  
• Julian Nemirovsky,
  
• Harold Eugene Jr. Ford,
  
• Jay Varma,
  EVP & Chief Medical Officer